THELMA Therapeutics Co., Ltd. announced a private placement of 7,142,857 common shares at an issue price of KRW 700 per share for gross proceeds of KRW 4,999,999,900 on January 24, 2022. The transaction will involve participation from existing investor, H Report Co., Ltd. The shares have face value of KRW 500. The company will issue shares through third-party allotment method. Post the closing, the total number of shares issued by the company will increase from 24,553,927 shares to 31,696,784 shares. The shares issued in the transaction will have a hold period of 12 months from the date of issuance. The payment date is February 28, 2022. The transaction has been approved by the board of directors of the company.